These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

372 related articles for article (PubMed ID: 19906236)

  • 1. Role of CRF receptor signaling in stress vulnerability, anxiety, and depression.
    Hauger RL; Risbrough V; Oakley RH; Olivares-Reyes JA; Dautzenberg FM
    Ann N Y Acad Sci; 2009 Oct; 1179():120-43. PubMed ID: 19906236
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Corticotropin releasing factor (CRF) receptor signaling in the central nervous system: new molecular targets.
    Hauger RL; Risbrough V; Brauns O; Dautzenberg FM
    CNS Neurol Disord Drug Targets; 2006 Aug; 5(4):453-79. PubMed ID: 16918397
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The role of corticotropin-releasing factor in depression and anxiety disorders.
    Arborelius L; Owens MJ; Plotsky PM; Nemeroff CB
    J Endocrinol; 1999 Jan; 160(1):1-12. PubMed ID: 9854171
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Carboxyl-terminal and intracellular loop sites for CRF1 receptor phosphorylation and beta-arrestin-2 recruitment: a mechanism regulating stress and anxiety responses.
    Oakley RH; Olivares-Reyes JA; Hudson CC; Flores-Vega F; Dautzenberg FM; Hauger RL
    Am J Physiol Regul Integr Comp Physiol; 2007 Jul; 293(1):R209-22. PubMed ID: 17363685
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Molecular and cell signaling targets for PTSD pathophysiology and pharmacotherapy.
    Hauger RL; Olivares-Reyes JA; Dautzenberg FM; Lohr JB; Braun S; Oakley RH
    Neuropharmacology; 2012 Feb; 62(2):705-14. PubMed ID: 22122881
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Corticotropin-releasing factor receptor signaling and modulation: implications for stress response and resilience.
    Vasconcelos M; Stein DJ; Gallas-Lopes M; Landau L; de Almeida RMM
    Trends Psychiatry Psychother; 2020 Jun; 42(2):195-206. PubMed ID: 32696892
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The blockade of corticotropin-releasing factor 1 receptor attenuates anxiety-related symptoms and hypothalamus-pituitary-adrenal axis reactivity in mice with mild traumatic brain injury.
    Kosari-Nasab M; Sadeghi T; Bashiri H; Shokouhi G; Salari AA
    Behav Pharmacol; 2019 Apr; 30(2 and 3-Spec Issue):220-228. PubMed ID: 30883392
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Corticotropin-releasing factor receptors 1 and 2 in anxiety and depression.
    Reul JM; Holsboer F
    Curr Opin Pharmacol; 2002 Feb; 2(1):23-33. PubMed ID: 11786305
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The corticotropin-releasing factor (CRF)(1) receptor antagonists CP154,526 and DMP695 inhibit light-induced phase advances of hamster circadian activity rhythms.
    Gannon RL; Millan MJ
    Brain Res; 2006 Apr; 1083(1):96-102. PubMed ID: 16551464
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Therapeutic utility of non-peptidic CRF1 receptor antagonists in anxiety, depression, and stress-related disorders: evidence from animal models.
    Kehne JH; Cain CK
    Pharmacol Ther; 2010 Dec; 128(3):460-87. PubMed ID: 20826181
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Icariin attenuates chronic mild stress-induced dysregulation of the LHPA stress circuit in rats.
    Pan Y; Wang FM; Qiang LQ; Zhang DM; Kong LD
    Psychoneuroendocrinology; 2010 Feb; 35(2):272-83. PubMed ID: 19631474
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The phenotypic differentiation of locus ceruleus noradrenergic neurons mediated by brain-derived neurotrophic factor is enhanced by corticotropin releasing factor through the activation of a cAMP-dependent signaling pathway.
    Traver S; Marien M; Martin E; Hirsch EC; Michel PP
    Mol Pharmacol; 2006 Jul; 70(1):30-40. PubMed ID: 16569708
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Corticotropin-releasing factor overexpression gives rise to sex differences in Alzheimer's disease-related signaling.
    Bangasser DA; Dong H; Carroll J; Plona Z; Ding H; Rodriguez L; McKennan C; Csernansky JG; Seeholzer SH; Valentino RJ
    Mol Psychiatry; 2017 Aug; 22(8):1126-1133. PubMed ID: 27752081
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacological evidence supporting a role for central corticotropin-releasing factor(2) receptors in behavioral, but not endocrine, response to environmental stress.
    Pelleymounter MA; Joppa M; Ling N; Foster AC
    J Pharmacol Exp Ther; 2002 Jul; 302(1):145-52. PubMed ID: 12065711
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antidepressant-like Effect of Bacopaside I in Mice Exposed to Chronic Unpredictable Mild Stress by Modulating the Hypothalamic-Pituitary-Adrenal Axis Function and Activating BDNF Signaling Pathway.
    Zu X; Zhang M; Li W; Xie H; Lin Z; Yang N; Liu X; Zhang W
    Neurochem Res; 2017 Nov; 42(11):3233-3244. PubMed ID: 28758176
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Activation of CRF/CRFR1 signaling in the basolateral nucleus of the amygdala contributes to chronic forced swim-induced depressive-like behaviors in rats.
    Chen L; Li S; Cai J; Wei TJ; Liu LY; Zhao HY; Liu BH; Jing HB; Jin ZR; Liu M; Wan Y; Xing GG
    Behav Brain Res; 2018 Feb; 338():134-142. PubMed ID: 29080675
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Corticotropin-releasing factor 1 receptor antagonists: a patent review.
    Williams JP
    Expert Opin Ther Pat; 2013 Aug; 23(8):1057-68. PubMed ID: 23642023
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The CRF1 receptor, a novel target for the treatment of depression, anxiety, and stress-related disorders.
    Kehne JH
    CNS Neurol Disord Drug Targets; 2007 Jun; 6(3):163-82. PubMed ID: 17511614
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chronic stress-induced alterations in amygdala responsiveness and behavior--modulation by trait anxiety and corticotropin-releasing factor systems.
    Sandi C; Cordero MI; Ugolini A; Varea E; Caberlotto L; Large CH
    Eur J Neurosci; 2008 Nov; 28(9):1836-48. PubMed ID: 18973598
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Non-peptidic CRF1 receptor antagonists for the treatment of anxiety, depression and stress disorders.
    Kehne J; De Lombaert S
    Curr Drug Targets CNS Neurol Disord; 2002 Oct; 1(5):467-93. PubMed ID: 12769601
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.